Knowledge Center

Patent / Jan 01, 2013

Application of high dose compounds via inhalation for treatment of pulmonary diseases

Authors:
  • Pedro Mendes
  • Isabel Lopes
  • Jason Suggett
  • Phillip Nelson
Source:
WO 2013104892

The invention relates to the delivery of high doses of active pharmaceutical compds. via inhalation for the treatment of pulmonary diseases. A pharmaceutical formulation in the form of a powder suitable for inhalation comprises one or more active pharmaceutical ingredients, such as an antibiotic, a mucolytic agent and/or a buffer, wherein the formulation is free of carrier. A powder formulation comprising doxycycline monohydrate combined with sodium citrate filled into TwinCap devices was exemplified.

Also in the Knowledge Center

Related Content

¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð®

Make your drug soluble with ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® technology. ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more

Capabilities

Providing support for all stages of development and production.

Page
Read more

OWN it! Necessidades de Formação e Desenvolvimento FY24

Tenha um papel ativo no seu desenvolvimento pessoal. Siga o novo processo para identificar e planear as suas necessidades de formação e desenvolvimento para o ano fiscal 2024.

Page
Read more